Skip to content
Checked.be
Complete company report
Generated 05-09-2026
Active BE 0802.885.529Private limited company

NbCR

Arduinkaai 16 ·1000 Brussel, Belgium· 3 yrs active
Sector: Specialist medical practice (86220)
Conclusion Checked

NbCR has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €823k and a net result of €445k. Its solvency ranks better than 69% of 16012 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Based on the State Gazette, CBE and 2 annual accounts.
Key figures
Equity €823k
Net result €445k
Better than sector 69%
Active 3 yrs
Financial profile 5 of 5 axes measured · computed by Checked
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94
Bankruptcy probability (12 mo) Checked model v1 · free
0.3% Very low
0%0,5%1,5%4%10%≥25%

How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
More than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score FY 2025 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€80k
estimate, not credit advice
Score history
93 2024
100 2025
purely financial, excl. current insolvency signals
Score components
Liquidity Current ratio 2.78 (≥ 1.5) +10
Quick ratio Quick ratio 2.78 (≥ 1.0) +5
Leverage Debt/equity 0.25 (< 1.0) +10
Profitability ROE 54% (≥ 10%) +10
Interest coverage Interest coverage 6272.8× (≥ 3×) +8
Profit trend Net profit up YoY +5
Equity growth Equity growing YoY +3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview2 NBB filings
Annual accounts filed on 08-12-2025 with the NBB · fiscal year 2025 · micro schema
€0€200k€400k€600kOperating result 2024: €547k€547kNet result 2024: €376k€376kOperating result 2025: €649k€649kNet result 2025: €445k€445k20242025
Operating resultNet result
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 80.0% 63.4%
better than 69% of 16012 sector peers
Net result €445k €62k
better than 95% of 16004 sector peers
Equity €823k €132k
better than 91% of 16015 sector peers
Gross operating margin €743k €116k
better than 95% of 16015 sector peers
Total assets €1.03M €286k
better than 88% of 16020 sector peers
EBITDA
€711k
+26.1% 24-25
Net profit
€445k
+18.2% 24-25
Cash flow
€507k
+29.2% 24-25
Total assets
€1.03M
+84.0% 24-25
Equity
€823k
+117.9% 24-25
Working capital
€365k
+9.0% 24-25
Income taxes
€204k
+19.1% 24-25
Debt
€205k
+13.4% 24-25
Debt ≤ 1y
€205k
+16.3% 24-25
Current ratio
2.78
-4.1% 24-25
Quick ratio
2.78
-4.1% 24-25
Solvency
80.0%
+18.4% 24-25
Debt / equity
0.25
-48.0% 24-25
ROE
54.1%
-45.7% 24-25
ROA
43.3%
-35.7% 24-25
Interest coverage
6272.81
-92.9% 24-25
Figures by fiscal year and ratios
Change versus the prior fiscal year, coloured by direction (green = favourable).
Fiscal year2025 Δ2024 Δ
Depositmicro schemamicro schema
Revenue--
EBITDA+26.1%-
Net profit+18.2%-
Cash flow+29.2%-
Staff costs--
Income taxes+19.1%-
Dividends--
Total assets+84.0%-
Equity+117.9%-
Debt+13.4%-
of which ≤ 1y+16.3%-
of which > 1y--
Working capital+9.0%-
Employees (FTE)--
Ratios (computed)
20252024
Current ratio2.782.90
Quick ratio2.782.90
Working capital ratio35.5%59.9%
Solvency80.0%67.6%
Debt / equity0.250.48
Long-term debt ratio--
Interest coverage6272.8188858.88
Gross margin--
Net margin--
ROA43.3%67.4%
ROE54.1%99.7%
EBITDA margin--
Days sales outstanding--
Days payable outstanding--
Inventory turnover--
Days inventory (DSI)--
Balance-sheet composition 2025
Full annual accounts (21 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code20252024
Balance sheet, Assets
TOTAL ASSETS 20/58€1.03M€559k
Fixed assets 21/28€459k€48k
Tangible fixed assets 22/27€459k€48k
Current assets 29/58€569k€511k
Amounts receivable within one year 40/41€103k€247k
Cash & bank 54/58€462k€255k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.03M€559k
Equity 10/15€823k€377k
Contributions / capital 10/11€1k€1k
Reserves 13€822k€376k
Amounts payable 17/49€205k€181k
Amounts payable within one year 42/48€205k€176k
Trade debts payable within one year 44€1k€5k
Income statement
Gross operating margin 9900€743k€566k
Operating result 9901€649k€547k
Financial income 75€203€11
Financial charges 65€113€6
Result before taxes 9903€649k€547k
Income taxes 67/77€204k€171k
Net result for the period 9904€445k€376k
Result to be appropriated 9905€445k€376k
Legal Structure
NACE primary Specialist medical practice(86220)
Legal form Private limited company(610)
Incorporation19-06-2023
StatusActive
Postal code1000
Establishment units 1 location
NbCR
Arduinkaai 16, 1000 BrusselSpecialist medical practice
since 20232.346.915.196
Real-estate footprint Source: CBE × cadastre
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21812N1271/00H000 Brussels 2,575 m² 1 · 837 m² 64.9 m · 21 fl.
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 2 events
Next filing, fiscal year 2026, expected by 31-01-2027
2025
08-12
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
30-06
Financial Equity above €500kEq €823k ▲118%
2 profitable years in a row build equity to €823k.
2024
09-12
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage 0 of 1 acts read

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Credit advice verdict per customer and amount
Company registry (CBE) Crossroads Bank
Activities
Specialist medical practice86220
Names & trade names
Legal nameNL NbCR
Similar companies Comparable size · 7,915 of 16,586 companies in this sector with filed accounts
DOKTER KOEN THEUNISSEN BE 0784.865.305 · Kortenaken
POLYCLINIQUE CLEMENCEAU BE 0454.971.471 · Anderlecht
Dr. Johan Dehem BE 0860.263.702 · Zonnebeke
Dr. Hilde Vandecauter BE 0474.385.725 · Sint-Laureins
Ortho-device BE 0839.691.782 · Alken
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative

We would like to set cookies. That happens only with your consent. What we measure